Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.17
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.22
0.33%
After-hours: Aug 15, 2025, 06:46 PM EDT
Immunovant Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -447.3M | -413.84M | -382.71M | -323.01M | -272.55M | -259.34M | -243.45M | -255.26M | -244.52M | -210.96M | -198.7M | -176.86M | -166.63M | -156.73M | -137.72M | -128.11M | -111.19M | -107.43M | -99.82M | -68.06M | -47.15M |
Depreciation & Amortization | 404K | 377K | 332K | 758K | 725K | 698K | 975K | 499K | 489K | 480K | 178K | 162K | 144K | 126K | 109K | 95K | 81K | 65K | 49K | 30K | 16.01K |
Stock-Based Compensation | 54.54M | 49.49M | 37.81M | 26.17M | 13.49M | 41.06K | 38.93K | 37.59K | 35.14K | 7.71M | 19.57M | 29.72M | 38.07M | 34.24M | 27.87M | 23.7M | 18.7M | 18.82M | 15.17M | 9.18M | 5.83M |
Other Working Capital | -22.4M | -25.69M | -5.81M | -8.04M | 1.28M | -14.13M | -12.11M | -11.11M | -15.34M | -5.49M | -26.7M | -24.7M | -19.99M | -1.11M | 12.08M | 17.7M | 5.24M | 3.31M | 115K | -5.68M | -913.59K |
Other Non-Cash Items | 91K | 6.94M | 17.71M | 28.78M | 29.05M | 47.34M | 36.84M | 26.02M | 26.01M | 1.13M | 1.12M | 375K | 1.11M | 1.11M | 1.05M | 1.79M | 1.05M | 933K | 845K | 563.82K | -398.32K |
Deferred Income Tax | n/a | n/a | 36.14M | 24.87M | 24.87M | n/a | -36.14M | -24.87M | -24.87M | n/a | n/a | n/a | -571K | n/a | -765K | -76K | 263K | -282K | 483K | -206K | 26K |
Change in Working Capital | -24.82M | -12.03M | 9.6M | 4.39M | -15.55M | 2.63M | -7.24M | 6.61M | 38.14M | -10.85M | -4.57M | -12.4M | -22.84M | 15.14M | 13.8M | 16.02M | 350K | 4.57M | -608K | -2.58M | 4.53M |
Operating Cash Flow | -417.09M | -375.87M | -324.94M | -271.64M | -243.06M | -214.23M | -210.32M | -209.62M | -169.74M | -188.19M | -165.36M | -150.86M | -150.72M | -106.11M | -95.65M | -86.57M | -90.74M | -83.33M | -83.88M | -61.07M | -37.15M |
Capital Expenditures | -577K | -759K | -708K | -659K | -497K | -360K | -236K | -203K | -200K | -197K | -289K | -265K | -278K | -254K | -231K | -186K | -181K | -210K | -125K | -96.01K | -57.02K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -577K | -759K | -708K | -659K | -497K | -360K | -236K | -203K | -200K | -197K | -289K | -265K | -278K | -254K | -231K | -186K | -181K | -210K | -125K | -96.01K | -57.02K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -202K | -202K | -202K | -202K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 686K | 2.23M | 472.07M | 472.22M | 472.43M | 471.12M | 71.9M | 71.75M | 70.89M | 270.65M | 200.02M | 400.06M | 400.13M | 200.89M | 201.34M | 1.1M | 194.56M | 193.9M | 193.56M | 193.8M |
Financial Cash Flow | 456.72M | 454.49M | 5.42M | 472.81M | 472.22M | 472.43M | 471.12M | 71.9M | 71.75M | 70.89M | 70.65M | 21K | 200.06M | 200.13M | 200.89M | 201.34M | 189.65M | 383.11M | 382.45M | 382.11M | 193.8M |
Net Cash Flow | 38.91M | 78.61M | -316.25M | -539.34M | -512.31M | -483.52M | -484.03M | -135.84M | -97.25M | -117.28M | -94.39M | -153.18M | 48.2M | 93.67M | 105.03M | 114.58M | 98.73M | 299.57M | 298.44M | 320.95M | 156.55M |
Free Cash Flow | -417.66M | -376.63M | -325.64M | -272.3M | -243.55M | -214.59M | -210.56M | -209.82M | -169.94M | -188.39M | -165.65M | -151.12M | -151M | -106.37M | -95.88M | -86.76M | -90.92M | -83.54M | -84.01M | -61.17M | -37.21M |